IP Library › Assignment 023988/0465

Patent Assignment

Reel/Frame 023988/0465

Change of Name

Recorded: 2010-02-25 Pages: 8

View PDF Order Certified Copy

Assignor

WYETH

Executed: 2009-11-09

Assignee

WYETH LLC

FIVE GIRALDA FARMS, MADISON, NEW JERSEY, 07940

Covered Properties (31)

Scent Ectoparasiticidal Formulation

Application: 61/154,520 →

Novel Process, Purification and Crystallization of 1-(4-{[4-(Dimethylamino)Piperidin-1-Yl]Carbonyl}Phenyl)-3-[4-(4,6-Dimorpholin-4- Yl-1,3,5-Triazin-2-Yl)Phenyl]Urea, PI3K/Mtor Inhibitor

Application: 61/154,562 →

Methods of Purifying Small Modular Immunopharmaceutical Proteins

Application: 61/159,347 →

Novel Nitration of Tetracyclines

Application: 61/159,466 →

PKN3/RhoC Macromolecular Complex and Methods of Use Therefor

Application: 61/159,739 →

Methods for the Preparation of [2-(8,9-Dioxo-2,6-Diazabicyclo[5.2.0]Non-1(7)-En-2-Yl)Ethyl]Phosphonic Acid and Precursors Thereof

Application: 61/161,513 →

Membrane Evaporation for Generating Highly Concentrated Protein Therapeutics

Application: 61/162,743 →

Treatment Regimen Utilizing Neratinib for Breast Cancer

Application: 61/166,796 →

Pyrimidine Compounds, Their Use as Mtor Kinase and PI3 Kinase Inhibitors, and Their Syntheses

Application: 61/170,138 →

5,6,7,8-Tetrahydropyrido[3,4-D]Pyrimidine Compounds, Their Use as Mtor Kinase and PI3 Kinase Inhibitors, and Their Syntheses

Application: 61/170,154 →

5,6,7,8-Tetrahydropyrido[4,3-D]Pyrimidine Compounds, Their Use as Mtor, PI3, and Hsmg-1 Kinase Inhibitors, and Their Syntheses

Application: 61/170,210 →

Ring Fused, Ureidoaryl- and Carbamoylaryl-Bridged Morpholino-Pyrimidine Compounds, Their Use as MTOR Kinase and PI3 Kinase Inhibitors, and Their Syntheses

Application: 61/170,293 →

Ureidoaryl- and Carbamoylaryl-Morpholino-Pyrimidine Compounds, Their Use as MTOR Kinase and PI3 Kinase Inhibitors, and Their Syntheses

Application: 61/170,328 →

Bisaryl Alkynylamides as Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5 (MGLUR5)

Application: 61/171,878 →

Parasiticidal Combinations of Macrocyclic Lactones and Polyether Antibiotics

Application: 61/173,299 →

Blood Parasiticide

Application: 61/174,811 →

Orally Administered Tablet Formulation of an Antianxiolytic Compound

Application: 61/177,379 →

Method to Stabilize a Dietary Supplement to Facilitate Joint Health in Humans

Application: 61/177,888 →

Burst Drug Release Compositions

Application: 61/177,943 →

Single-Use, Disposable Strip for Application of Topical Compositions

Application: 61/180,463 →

SUBSTITUTED IMIDAZO[1,5-a]QUINOXALINES AS INHIBITORS OF PHOSPHODIESTERASE 10

Application: 61/182,554 →

11-beta HSD1 Inhibitors

Application: 61/184,120 →

Lyophilized Formulations for Small Modular Immunopharmaceuticals

Application: 61/218,386 →

Lyophilized Formulations for Small Modular Immunopharmaceuticals

Application: 61/218,388 →

Slow Dissolution Method for Reconstitution of Lyophilized Material

Application: 61/218,390 →

Immunogenic Compositions of Staphylococcus Aureus Antigens

Application: 61/219,134 →

Compositions and Methods for Preparing Staphylococcus Aureus Serotype 5 Capsular Polysaccharide Conjugate Immunogenic Compositions

Application: 61/219,143 →

Sodium Ibuprofen Tablets and Methods of Manufacturing Pharmaceutical Compositions Including Sodium Ibuprofen

Application: 61/219,149 →

Compositions and Methods for Preparing Staphylococcus Aureus Serotype 8 Capsular Polysaccharide Conjugate Immunogenic Compositions

Application: 61/219,151 →

PKN3/Rhoc Macromolecular Complex and Methods of Use Therefor

Application: 61/226,078 →

Compositions Comprising Adjuvant, Macrolide and Proteineceous Antigen and Methods of Use Thereof

Application: 61/249,454 →

Related Assignments (25)

Other recorded transfers of the patents in this record — the chain of ownership.